Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference January 16, 2026 Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, and alopecia areata, with 3 ongoing PoC/Phase II clinical studies* and 3 additional studies to be initiated in 2026. Almirall’s sustained trajectory of growth and profitability enables the company to reach more patients and supports a growth outlook of double-digit net sales through 2030, combined biologics peak sales of approximately €800 MM (Ebglyss® and Ilumetri®), and a 25% EBITDA margin by 2028. Almirall's leadership in medical dermatology, biologics growth, and continued strong performance of its broad product portfolio fuel advancement of a diversified and innovative R&D pipeline addressing skin diseases with high unmet need.
The Delivery Conference 2026 Announces Agenda, Key Speakers, and Closing Keynote Richard Ayoade January 16, 2026 TDC 2026 unites global leaders to shape the future of AI-powered delivery Keynote insights from Mary Portas, Arka Dhar, Richard Lim, Richard Ayoade, and others Closing-party performance from British music and West End star, Alexandra Burke
Kolibri Global Energy Inc. Provides Operations Update January 16, 2026 Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) is pleased to provide an operations update on its latest wells in its Tishomingo field in Oklahoma. BARNES WELLS The Barnes 6-31-2H and Barnes 6-4H wells (both 100% working interest) have been on production for approximately 30 days. The 1.5 mile lateral Barnes [...]
SOLUM to Unveil Future Vision for Smart Retail at NRF 2026: ‘Empowering Offline Stores through Data Synergy’ January 9, 2026 - 'Retail in Sync': Realizing 'Store Intelligence' by converging data beyond simple device connectivity - Introduces 'SSP' (SOLUM Store Platform): Setting the standard for digital transformation (DX) in physical retail - Four immersive Experience Zones to showcase 45 years of technological heritage and global partnership expansion
Kashiv BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conference January 6, 2026 Kashiv BioSciences, LLC (“Kashiv”), a vertically integrated biopharmaceutical company, today announced that Dr. Sandeep Athalye, Global Chief Executive Officer, and Dr. Paras Vasanani, Head of Business Development, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Wednesday, January 14, 2026, at 11:00 a.m. PST. 44th Annual J.P. Morgan Healthcare [...]
Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium January 6, 2026 Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% for 10 patients with HER2+ oesophageal cancer who had received prior therapy that included a trastuzumab component in at least one prior treatment
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference December 30, 2025 Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, Jan. 13, 2026 at 10:30 a.m. PST (1:30 p.m. EST/6:30 p.m. GMT). The live webcast may be accessed under the [...]
LivaNova to Present at J.P. Morgan Healthcare Conference in January December 23, 2025 LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30 p.m. Pacific Standard Time. [...]
Lattice to Showcase its Latest FPGA Technology Innovations at the International VLSID Conference December 23, 2025 ‒ Pravin Desale, Head of R&D, to Deliver Keynote on Growing Need for Low Power FPGAs ‒ ‒ Multiple Technical Sessions Focused on Edge AI, Sensor Fusion, System Design, and More ‒
IDWS 2025 Concludes with Focus on Global Knowledge Exchange, Financial Opportunities, and Scalable Water Solutions December 16, 2025 The 4th Innovation Driven Water Sustainability Conference (IDWS) 2025 concluded on Wednesday in Jeddah, confirming its status as one of the world’s most influential platforms for shaping the future of water innovation, sustainability, and security. Gathering senior global policymakers and international industry leaders, this year’s edition has advanced critical dialogue on safeguarding the planet’s most [...]